Travis Blackburn
Surgical · Vestavia, ALNPI 1396282026
Payments from drug & device makers
What this record shows
Boston Scientific accounts for 64.1% of it on its own, with 7 other manufacturers making up the rest.
Across 23 payments — averaging $71.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Endo USA, Inc.$160
- Antares Pharma, Inc.$156
- Medshape, Inc.$118
- Sumitomo Pharma America, Inc.$50
- DJO, LLC$43
- plus $62 from 2 others
What the payments were for
- Travel & lodging$72144%
- Food & beverage$92056%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $1,052 |
| Endo USA, Inc. | 4 | $160 |
| Antares Pharma, Inc. | 3 | $156 |
| Medshape, Inc. | 1 | $118 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| DJO, LLC | 1 | $43 |
| Tolmar, Inc. | 2 | $42 |
| Amgen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- rezum Generator$836
- XYOSTED$118
- DynaNail$118
- DynaNail Hybrid$118
- XIAFLEX$104
How this compares
$1,641 in reported general payments places this provider in the 75th percentile of 162 surgical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 59 | $825 |
| Oseltamivir Phosphate | 16 | $469 |
| Azithromycin | 75 | $460 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $356 |
| Doxycycline Hyclate | 37 | $310 |
| Cephalexin | 39 | $262 |
| Prednisone | 146 | $250 |
| Ondansetron OdtOndansetron | 13 | $231 |
| Ofloxacin | 11 | $206 |
| Methylprednisolone | 18 | $166 |
| Fluconazole | 11 | $85 |
| Methocarbamol | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Other surgical in Vestavia
- Jennifer RawlingsVestavia$7K
- Jamie GoberVestavia$2K
- Catherine FaughtVestavia$1K
- Michael CilimbergTuscaloosa$10K
- Heather ForsonBirmingham$8K
- Kelli HeerDothan$8K
- Suzanne Powe VickersBirmingham$8K
- Erica AbneyTuscaloosa$8K
- Chelsi DavisJasper$7K
- Samuel MurphreeBirmingham$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.